South Africa on Sunday suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine, after a small clinical trial suggested that it isn't effective in preventing mild to moderate illness from the variant dominant in the country, The Associated Press reports.
South Africa got its first 1 million doses of the AstraZeneca vaccine last week and was expected to begin giving shots to health care workers in mid-February.